Kindos Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KINDOS, and what generic and branded alternatives to KINDOS drugs are available?
KINDOS has eight approved drugs.
Drugs and US Patents for Kindos
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kindos | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 216040-001 | Dec 27, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Kindos | NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 216038-001 | Jan 10, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Kindos | PLERIXAFOR | plerixafor | SOLUTION;SUBCUTANEOUS | 215698-001 | Jul 24, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |